Literature DB >> 23001093

Young stroke due to vascular anomaly from neurofibromatosis type 1.

Vachagan Krishnaswami1, James Gilmore, Djamil Vahidassr.   

Abstract

Aetiology of stroke in young is often different to that of an older person. In nearly half of these cases no cause is established. Every effort should be explored to establish a cause as treatment varies accordingly and the prognosis with rehabilitation is favourable when compared with older people. We present a case of pontine infarct in a 43-year-old man due to vascular ectasia associated with neurofibromatosis type 1. Following the stroke, the patient went through intensive rehabilitation where he had a good functional outcome.

Entities:  

Mesh:

Year:  2012        PMID: 23001093      PMCID: PMC4542882          DOI: 10.1136/bcr-2012-006258

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Diagnostic strategies in young patients with ischemic stroke in Canada.

Authors:  M T Chan; Z G Nadareishvili; J W Norris
Journal:  Can J Neurol Sci       Date:  2000-05       Impact factor: 2.104

Review 2.  Research update and recent developments in the management of scoliosis in neurofibromatosis type 1.

Authors:  Zhenyu Wang; Yi Liu
Journal:  Orthopedics       Date:  2010-05       Impact factor: 1.390

3.  Novel mutation of neurofibromatosis type 1 in a patient with cerebral vasculopathy and fatal ischemic stroke.

Authors:  Sung-Chun Tang; Ming-Jen Lee; Jiann-Shing Jeng; Ping-Keung Yip
Journal:  J Neurol Sci       Date:  2006-01-18       Impact factor: 3.181

4.  Neurofibromatosis, stroke and basilar impression. Case report.

Authors:  E J Piovesan; R H Scola; L C Werneck; V H Zétola; E M Nóvak; F M Iwamoto; L M Piovesan
Journal:  Arq Neuropsiquiatr       Date:  1999-06       Impact factor: 1.420

Review 5.  Causes of ischaemic stroke in the young.

Authors:  P J Martin; T P Enevoldson; P R Humphrey
Journal:  Postgrad Med J       Date:  1997-01       Impact factor: 2.401

6.  Neurological complications of neurofibromatosis type 1 in adulthood.

Authors:  A Créange; J Zeller; S Rostaing-Rigattieri; P Brugières; J D Degos; J Revuz; P Wolkenstein
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

Review 7.  Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.

Authors:  Tena L Rosser; Gilbert Vezina; Roger J Packer
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

8.  Cerebral arteriopathy in children with neurofibromatosis type 1.

Authors:  David Rea; John F Brandsema; Derek Armstrong; Patricia C Parkin; Gabrielle deVeber; Daune MacGregor; William J Logan; Rand Askalan
Journal:  Pediatrics       Date:  2009-08-24       Impact factor: 7.124

9.  Comparison of stroke features and disability in daily life in patients with ischemic stroke aged 55 to 70 and 71 to 85 years.

Authors:  T Pohjasvaara; T Erkinjuntti; R Vataja; M Kaste
Journal:  Stroke       Date:  1997-04       Impact factor: 7.914

10.  Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results.

Authors:  Gustavo S Oderich; Timothy M Sullivan; Thomas C Bower; Peter Gloviczki; Dylan V Miller; Dudica Babovic-Vuksanovic; Thanila A Macedo; Anthony Stanson
Journal:  J Vasc Surg       Date:  2007-07-30       Impact factor: 4.268

  10 in total
  2 in total

1.  Coexistence of Neurofibromatosis Type-1 and MTHFR C677T Gene Mutation in a Young Stroke Patient: A Case Report.

Authors:  Halim Yilmaz; Gulten Erkin; Haluk Gumus; Lutfiye Nalbant
Journal:  Case Rep Neurol Med       Date:  2013-02-27

2.  Giant thrombosed intracavernous carotid artery aneurysm presenting as Tolosa-Hunt syndrome in a patient harboring a new pathogenic neurofibromatosis type 1 mutation: a case report and review of the literature.

Authors:  Renata Conforti; Mario Cirillo; Valeria Marrone; Rosario Galasso; Guglielmo Capaldo; Teresa Giugliano; Assunta Scuotto; Giulio Piluso; Mariarosa Ab Melone
Journal:  Neuropsychiatr Dis Treat       Date:  2014-01-20       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.